If you have a heart arrhythmia like Afib, your doctor may recommend cardioversion for treatment - a process that DCRI's Jonathan Piccini says is "like rebooting a computer that has crashed." Learn more about what this treatment process entails here: https://lnkd.in/dARyNS7j #clinicalresearch #arrhythmia #Afib
Duke Clinical Research Institute
Research Services
Durham, North Carolina 18,328 followers
Developing & sharing knowledge that improves health around the world through innovative clinical research.
About us
As part of the Duke University School of Medicine, the Duke Clinical Research Institute (DCRI) is known globally for conducting groundbreaking multinational trials, managing major national patient registries, and performing landmark research. As an academic clinical research organization, we combine the faculty expertise of practicing physicians with the full-service operational capabilities of a major CRO. We design and implement innovative clinical trials that advance the understanding of health and disease and inform efforts to improve the quality of care. Our experience stretches from phase I to phase IV and beyond, encompassing post-approval analyses and health economics. The breadth of our work in numerous therapeutic areas is matched by the depth of our knowledge, which we disseminate through high-impact publications and global meetings. Since 1996, DCRI's faculty and staff have disseminated over 17,500 peer-reviewed publications and have been cited in over 760,500 scientific articles.
- Website
-
https://dcri.org
External link for Duke Clinical Research Institute
- Industry
- Research Services
- Company size
- 1,001-5,000 employees
- Headquarters
- Durham, North Carolina
- Type
- Educational
- Founded
- 1969
Locations
-
Primary
300 W Morgan St
Durham, North Carolina 27701, US
Employees at Duke Clinical Research Institute
Updates
-
During this year's American Thoracic Society conference, DCRI faculty member Aparna Swaminathan presented new study results showing how patient genetic information combined with clinical data can better help predict short-term outcomes for patients with IPF. Read more about the study, which also featured contributions from DCRI faculty members Megan Neely and Jamie Todd: https://lnkd.in/eiR368dJ #clinicaltrials #clinicalresearch #IPF #pulmonary
DCRI Unveils New Imaging and Translational Biomarker Evidence in Pulmonary Fibrosis and Lung Disease from the IPF-PRO/ILD-PRO Registry
dcri.org
-
Real-world data has the potential to enhance clinical trials across all steps and phases – yet many hurdles remain before this data can be leveraged broadly. This past May, the DCRI Think Tank sat down to explore the potential of RWD and what barriers need to be overcome to make application accepted by regulators and healthcare communities. Read the full meeting brief below, and check out past Think Tank briefs and publications at: https://lnkd.in/eB8jWWu5 #clinicaltrials #clinicalresearch #realworlddata #thinktank
-
Valvular heart disease treatment has made impressive progress over the last two decades - yet not everyone is experiencing the benefits, even with new FDA guidance aimed at increasing diversity in clinical trials. For DCRI's Sreekanth Vemulapalli, one of the key areas that needs improvement is increase the diversity of patients at the beginning of the care pathway, but finding that exact time can be tricky: https://lnkd.in/eX4Cvydm #clinicaltrials #clinicalresearch #heartdisease #healthequity
Valvular Heart Disease Has a Diversity Problem
tctmd.com
-
New study results have shown bariatric surgery and the weight loss drug tirzepatide can help reduce obstructive sleep apnea. For DCRI's Nishant Shah, there is an "urgency to aggressively battle obesity" in the U.S., and results like these support the idea of treating OSA and other cardiometabolic parameters in various clinical settings. Learn more: https://lnkd.in/efjtJr4c #sleepapnea #obesity #clinicaltrials #clinicalresearch
Weight-Loss Drug Tirzepatide Reduces Severity of Obstructive Sleep Apnea
tctmd.com
-
During a secondary analysis of the ADAPTABLE trial, experts including the DCRI’s Lisa Wruck, Adrian Hernandez, and Schuyler Jones found no major sex-specific differences regarding safety and effectiveness when taking two aspirin doses for the secondary prevention of ASCVD events. Read the full report here: https://lnkd.in/eZU2vPjt #clinicaltrials #clinicalresearch #ASCVD #hearthealth
Aspirin Dosing for CVD Prevention in Male and Female Patients
jamanetwork.com
-
Have you noticed your heart beating faster when standing up or bending down? As DCRI’s Jonathan Piccini, MD, MHS explains, this is due to the blood flow into the right side of the heart changing, which can in turn cause extra beats. While this is normal for many, for others, this can be a potential indicator of postural tachycardia syndrome. Read more to see what Dr. Piccini and other experts have to say about spotting the signs of POTS and what treatment options are available: https://lnkd.in/eMKCdwrA #hearthealth #POTS #cardiology
Heart Palpitations When Bending Over: Causes & Remedies
healthcentral.com
-
By using data from the Project Baseline Health Study’s investigational wearable devices, DCRI’s Jessilyn Dunn, Svati Shah, Melissa Daubert, Pamela Douglas, and other researchers have gathered new evidence on how walking behaviors can potentially indicate signs of early-stage heart failure. Read more about how these wearables could help compliment clinical testing for identifying and monitoring pre-symptomatic HF: https://lnkd.in/eVDc8aXv #clinicaltrials #clinicalresearch #wearables #heartfailure
Real-world walking behaviors are associated with early-stage heart failure: a Project Baseline Health Study
onlinejcf.com
-
In the past 100 years, cardiovascular disease research and treatment has undergone massive changes. But what will the next 100 years hold? DCRI's Adrian Hernandezz joins other experts to discuss three key areas that they expect to be important factors in the next century: https://lnkd.in/eXVpHKnZ #clinicalresearch #clinicaltrials #cardiology #heartdisease
What might the next century hold for cardiovascular disease prevention and care?
heart.org
-
Congratulations to our 2024 Career Service Award recipients! This year, we had 102 recipients representing a combined 1,675 years of service. Join us in giving them a big thank you for their years of fantastic work! #clinicaltrials #clinicalresearch #employeeappreciation #careerservice
-